跳至主要内容
临床试验/KCT0008693
KCT0008693尚未招募Unknown

A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in unicondylar knee arthroplasty (UKA) Procedure

Smith & Nephew0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1 Subject is a suitable candidate for a UKA procedure using CORI and a compatible S+N Knee Implant System.
  • 2 Subject requires a cemented UKA as a primary indication that meets any of the following conditions:
  • a) Non-inflammatory degenerative joint disease, including osteoarthritis
  • b) Avascular necrosis
  • c) Requires correction of functional deformity
  • d) Requires treatment of fractures that were unmanageable using other techniques
  • 3 Subject is of legal age to consent and considered skeletally mature (= 18 years of age at the time of surgery)
  • 4 Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethics Committee (EC) or Institutional Review Board (IRB) approved informed consent form.
  • 5 Subject plans to be available through one (1) year postoperative follow-up.
  • 6 Applicable routine radiographic assessment is possible.

排除标准

  • 1 Subject receives a UKA on the index joint as a revision for a previously failed surgery, or need for complex implants, or any other implant than a standard UKA (e.g. stems, augments, or custom made devices).
  • 2 Subject has been diagnosed with post-traumatic arthritis
  • 3 Subject receives simultaneous bilateral UKA OR a unilateral UKA with contralateral TKA.
  • 4 Subject has one or more of the following arthroplasties that are not fully healed and well-functioning, as determined by the investigator:
  • -Contralateral primary TKA or UKA, however, the subject can only have one knee enrolled in the study.
  • 5 Subject does not understand the language used in the Informed Consent Form.
  • 6 Subject does not meet the indication or is contraindicated for UKA according to specific S+N knee system’s Instructions for Use (IFU).
  • 7 Subject has active infection or sepsis (treated or untreated).
  • 8 Subject is morbidly obese with a body mass index (BMI) greater than 40.
  • 9 Subject is pregnant or breast feeding at the time of surgery.
  • 10 Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure.
  • 11 Subject currently enrolled in another orthopedic clinical trial study.
  • 12 Subject has a condition(s) that may interfere with the UKA survival or outcome (i.e., Paget’s or Charcot’s disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection).
  • 13 Subject in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, intellectual disability, drug or alcohol abuse.
  • 14 Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint.
  • 15 Subject is a prisoner or meets the definition of a Vulnerable Subject per ISO 14155:2020 Section 3.55.1

研究者

相似试验

A Prospective, Multi-center, Randomized Controlled... | 临床试验